Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus in Advanced Urothelial Carcinoma
NCT01801137Phase 2Completed
- Sponsor
- Hôpital Foch
- Start
- Jun 2011
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in transitional cell carcinoma of the urothelium (TCC), sponsored by Hôpital Foch. Started Jun 2011; status: completed.
02
Drugs
everolimus
03
Conditions
transitional cell carcinoma of the urothelium (TCC)
Beyond the preview
Go deeper on NCT01801137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01801137.